Texting parents could be key to curbing HPV-Related cancers
NCT ID NCT05006833
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This trial tests whether text messages to parents and a brief training for healthcare providers can increase HPV vaccination rates among 11- and 12-year-olds. The study involves over 8,000 adolescents and their parents across Florida clinics. Some clinics will use both interventions, while others will use only one or none, to see which approach works best.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Parent-targeted text messages and brief clinician training on HPV vaccine recommendation
- What this could lead to
- If effective, this approach could increase HPV vaccination rates among adolescents, potentially reducing HPV-related cancers.
- What could go wrong
- The trial is testing behavioral interventions, which may have limited impact. Results depend on parent and provider engagement, and the study is specific to Florida clinics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
8,043 people
The number who actually took part.
- Started
-
Nov 2021
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
10 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Adolescents * Age 10- to 12-years-old * Visited participating clinic in past two years * No records of the adolescent vaccines Parents * Parent of adolescent meeting the above criteria * Parent of 10- to 12-year-old Providers * Provide 11 to 12-year-old patients primary care * Practice at a participating clinic Exclusion Criteria: Adolescents * Out of the age range for participation * Previously opted-out of text messages * No cell phone numbers on file at clinic Parents/Providers * Unwilling to consent to participation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Florida
Gainesville, Florida, 32610, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an HPV shot stop vulvar lesions from coming back?
- MRI scans may reveal which throat cancer patients need stronger treatment
- Could a single HPV shot match the standard regimen?
- Could Self-Sampling revolutionize cervical cancer screening?
- Pocket-sized HIV test could bring same-day diagnosis to community clinics
- Can anal cancer treatment spare sexual well-being? a study tracks the toll over two years.